These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6819806)

  • 1. Prostaglandin synthetase inhibitors and their effects on the fetus and the newborn.
    Prasad RN
    Ann Acad Med Singap; 1982 Oct; 11(4):513-25. PubMed ID: 6819806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
    Loftin CD; Trivedi DB; Langenbach R
    J Clin Invest; 2002 Aug; 110(4):549-57. PubMed ID: 12189249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin biosynthetic pathways in fetal lamb ductus arteriosus and lung: relationship to ductal patency and closure.
    Printz MP; Friedman WF; Skidgel RA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():483-9. PubMed ID: 6221635
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular changes due to premature closure of the ductus arteriosus: a mathematical model.
    Huikeshoven FJ; Jongsma HW
    Eur J Obstet Gynecol Reprod Biol; 1985 Nov; 20(5):305-10. PubMed ID: 3935497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PG-synthetase inhibitors in obstetrics and after.
    Lancet; 1980 Jul; 2(8187):185-6. PubMed ID: 6105344
    [No Abstract]   [Full Text] [Related]  

  • 6. Ontogeny of the ductus arteriosus response to prostaglandins and inhibitors of their synthesis.
    Clyman RI
    Semin Perinatol; 1980 Apr; 4(2):115-24. PubMed ID: 6990502
    [No Abstract]   [Full Text] [Related]  

  • 7. Dilatation of the ductus arteriosus by prostaglandins and prostaglandin's precursors.
    Momma K; Uemura S; Nishihara S; Ota Y
    Pediatr Res; 1980 Sep; 14(9):1074-7. PubMed ID: 7192845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of fetal prostanoids, nitric oxide, and ductus arteriosus to the short- and long-term antenatal administration of celecoxib, a selective cyclo-oxygenase-2 inhibitor, in the pregnant rabbit.
    Hausman N; Beharry K; Nishihara K; Akmal Y; Stavitsky Y; Asrat T
    Am J Obstet Gynecol; 2003 Dec; 189(6):1744-50. PubMed ID: 14710108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat.
    Momma K; Toyoshima K; Ito K; Sugiyama K; Imamura S; Sun F; Nakanishi T
    Neonatology; 2009; 96(2):69-79. PubMed ID: 19225238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductus-dependent fetal cardiac defects contraindicate indomethacin tocolysis.
    Saenger JS; Mayer DC; D'Angelo LJ; Manci EA
    J Perinatol; 1992 Mar; 12(1):41-7. PubMed ID: 1560290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus.
    Friedman WF; Printz MP; Kirkpatrick SE
    Adv Prostaglandin Thromboxane Res; 1978; 4():373-81. PubMed ID: 565580
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of pulmonary prostaglandin biosynthetic and catabolic enzymes as factors in ductus arteriosus patency and closure. Evidence for a shift in products with gestational age.
    Printz MP; Skidgel RA; Friedman WF
    Pediatr Res; 1984 Jan; 18(1):19-24. PubMed ID: 6422431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin biosynthetic activities of isolated fetal lamb ductus arteriosus, other blood vessels, and lung tissue.
    Skidgel RA; Friedman WF; Printz MP
    Pediatr Res; 1984 Jan; 18(1):12-8. PubMed ID: 6583652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
    Hammerman C
    Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin in pregnancy: applications and safety.
    Abou-Ghannam G; Usta IM; Nassar AH
    Am J Perinatol; 2012 Mar; 29(3):175-86. PubMed ID: 21786219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs.
    Guerguerian AM; Hardy P; Bhattacharya M; Olley P; Clyman RI; Fouron JC; Chemtob S
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1618-26. PubMed ID: 9855607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the prostaglandin system to the control of muscle tone of the ductus arteriosus.
    Coceani F; Olley PM; Bishai I; Bodach E; White EP
    Adv Prostaglandin Thromboxane Res; 1978; 4():325-33. PubMed ID: 645510
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacology of the ductus arteriosus.
    Smith GC
    Pharmacol Rev; 1998 Mar; 50(1):35-58. PubMed ID: 9549757
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of effects of cyclooxygenase inhibitors on myometrial contraction and constriction of ductus arteriosus in rats.
    Karadas B; Kaya T; Bagcivan I; Kaloglu C; Guvenal T; Cetin A; Soydan AS
    Eur J Pharmacol; 2004 Feb; 485(1-3):289-98. PubMed ID: 14757153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors.
    Levin DL; Fixler DE; Morriss FC; Tyson J
    J Pediatr; 1978 Mar; 92(3):478-83. PubMed ID: 416191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.